Hep C Virus - Difficulty In Treating Older Hepatitis C Patients With Combination Therapy

Difficulty In Treating Older Hepatitis C Patients With Combination Therapy
Medical News Today - Jan 07 8:14 AM
A new study in Japan examining the effects of combination therapy on older patients with hepatitis C found more adverse effects necessitating discontinuation of treatment, lowering of dosages, and lower long-term benefits in this age group.Save to My Web

Anadys Pharmaceuticals to Present at the 24th Annual JP Morgan Healthcare Conference
[Press Release] PR Newswire via Yahoo! Finance - Jan 05 6:00 AM
Anadys Pharmaceuticals, Inc. announced today that it will present at the 24th Annual JP Morgan Healthcare Conference on Thursday, January 12, 2006 at 9:00 a.m. PST at the Westin St.Save to My Web

Vertex drug shows promise in hepatitis C
Pharmaceutical Business Review - Jan 10 6:04 PM
New data from a phase Ib study show that Vertex Pharmaceuticals VX-950 dosed in combination with pegylated interferon alfa-2a, achieved a rapid and dramatic reduction in virus levels in genotype 1 patients with chronic hepatitis C infection.Save to My Web

Organ Donor Rates for 2005 Worst Ever
Scoop.co.nz - Jan 10 12:32 PM
Organ Donor Rates for 2005 Worst Ever. Figures released today show that New Zealand has hit an all time low in the number of organ donors it has. Just 29 people became organ donors in 2005.Save to My Web

Hepatitis C treatment difficult in older patients
Reuters via Yahoo! News - Jan 18 11:25 AM
Because of side effects, patients over the age of 60 with hepatitis C find it more difficult to stick with standard treatments than do their younger counterparts, according to a study in Japan.Save to My Web